HLB Science: Introduction to innovative technologies.
In order to control the secondary immune response initiated by the endotoxins released from gram-negative
bacteria during sepsis treatment by antibiotics, our research institute has recently discovered a unique candidate “DD-S052P”.
Similar to polymyxin B (limited in clinical use due to the toxicity), “DD-S052P” has dual functions, it directly kill the bacteria and binds the endotoxins released as a byproduct of the killing process.
With low toxicity, “DD-S052P” is a promising candidate to treat endotoxin releasing gram negative bacterial infections and multidrug-resistant bacterial infections, which both are currently regarded as a serious public health issues.
An effective treatment strategy targeting Gram-negative bacteria and endotoxins that directly affect the onset of Alzheimer’s disease